<SEC-DOCUMENT>0001564590-17-024444-index.html : 20171201
<SEC-HEADER>0001564590-17-024444.hdr.sgml : 20171201
<ACCEPTANCE-DATETIME>20171201150211
ACCESSION NUMBER:		0001564590-17-024444
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20171130
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171201
DATE AS OF CHANGE:		20171201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MYRIAD GENETICS INC
		CENTRAL INDEX KEY:			0000899923
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				870494517
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26642
		FILM NUMBER:		171233970

	BUSINESS ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
		BUSINESS PHONE:		801-584-3600

	MAIL ADDRESS:	
		STREET 1:		320 WAKARA WAY
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84108
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mygn-8k_20171130.htm
<DESCRIPTION>8-K ANNUAL MTG
<TEXT>
Document 1 - file: mygn-8k_20171130.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>mygn-ex101_17.htm
<DESCRIPTION>EX-10.1 2017 EQUITY COMPENSATION PLAN
<TEXT>
Document 2 - file: mygn-ex101_17.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>mygn-ex102_44.htm
<DESCRIPTION>EX-10.2 2013 EXECUTIVE INCENTIVE PLAN
<TEXT>
Document 3 - file: mygn-ex102_44.htm

</DOCUMENT>
</SEC-DOCUMENT>